Subscribe
aga7ta-shutterstock-com
aga7ta / Shutterstock.com
8 February 2016Americas

Federal Circuit revives catheter patents dispute

The US Court of Appeals for the Federal Circuit has revived medical device company TriReme Medical’s attempt to correct the record of three patents related to catheters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.

More on this story

Americas
Inventor wins $1.2m from Medcomp and Martech over infringed catheter device
18 January 2021   Sister medical device companies, Medical Components and Martech Medical Products, are liable for $1.2 million after a federal court in Pennsylvania ruled that both infringed a patent covering the design of a handle on a medical device.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York